NEW DELHI, Sept 6 (Reuters) – Bharat Biotech’s COVID-19 recombinant nasal vaccine has been approved by the Indian drug regulator, the country’s health minister Mansukh Mandaviya tweeted on Tuesday.The regulator approved the vaccine for primary immunisation of those aged 18 years and above, for restricted use in emergency situations, Mandaviya added.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
